Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 8. Response to aromatase inhibitor and cyclin dependent kinase inhibitor in metastatic hormone receptor+, HER2 negative breast cancer. In this 29-year-old.

Published byGrace Williamson Modified over 6 years ago

Similar presentations

Presentation on theme: "Fig. 8. Response to aromatase inhibitor and cyclin dependent kinase inhibitor in metastatic hormone receptor+, HER2 negative breast cancer. In this 29-year-old."— Presentation transcript:

1 Fig. 8. Response to aromatase inhibitor and cyclin dependent kinase inhibitor in metastatic hormone receptor+, HER2 negative breast cancer. In this 29-year-old woman, baseline coronal CT (A) demonstrates multiple liver metastases (arrow). Follow-up coronal contrast-enhanced CT (B) demonstrates decreased size of multiple liver lesions (arrow) representing response to treatment. HER2 = human epidermal growth factor receptor 2 Fig. 8. Response to aromatase inhibitor and cyclin dependent kinase inhibitor in metastatic hormone receptor+, HER2 negative breast cancer. In this 29-year-old woman, baseline coronal CT (A) demonstrates multiple liver metastases (arrow). Follow-up coronal contrast-enhanced CT (B) demonstrates decreased size of multiple liver lesions (arrow) representing response to. . . Korean J Radiol Jan-Feb;18(1):

Download ppt "Fig. 8. Response to aromatase inhibitor and cyclin dependent kinase inhibitor in metastatic hormone receptor+, HER2 negative breast cancer. In this 29-year-old."

Similar presentations

Fig. 2. Computed tomography (CT) and magnetic resonance images of 34-year-old man with right nasal tumor diagnosed as cavernous hemangioma. A. Early-phase.

Fig. 2. Computed tomography (CT) and magnetic resonance images of 34-year-old man with right nasal tumor diagnosed as cavernous hemangioma. A. Early-phase.
Fig. 1. 18FDG PET-CT in patient with cutaneous T-cell lymphoma with treatment response. Baseline (A) and post treatment (B) axial fused PET-CT images demonstrate.

Fig FDG PET-CT in patient with cutaneous T-cell lymphoma with treatment response. Baseline (A) and post treatment (B) axial fused PET-CT images demonstrate.
Fig. 3. Gadoxetic acid-enhanced MRI in 69-year-old man with chronic hepatitis C.On arterial phase (A), 1.2 cm enhancing nodule is seen in S8 (arrows),

Fig. 3. Gadoxetic acid-enhanced MRI in 69-year-old man with chronic hepatitis C.On arterial phase (A), 1.2 cm enhancing nodule is seen in S8 (arrows),
Fig year-old boy with Burkitt lymphoma. A

Fig year-old boy with Burkitt lymphoma. A
Fig. 2. Kaplan-Meier curves for survival in each breast cancer molecular subtype. Radiologic assessment in triple-negative breast cancer (A), HER2-positive.

Fig. 2. Kaplan-Meier curves for survival in each breast cancer molecular subtype. Radiologic assessment in triple-negative breast cancer (A), HER2-positive.
Fig year-old man with CLL and transformation to DLBCL. A

Fig year-old man with CLL and transformation to DLBCL. A
Fig year-old woman with invasive lobular breast cancer. A

Fig year-old woman with invasive lobular breast cancer. A
74-year-old man with stage T2a Gleason score 3 + 4 prostate cancer (prostate specific antigen = 14.56 ng/mL) in right transition zone (TZ) with history.

74-year-old man with stage T2a Gleason score prostate cancer (prostate specific antigen = ng/mL) in right transition zone (TZ) with history.
Fig. 1. Luminal A type breast cancer of 37-year-old woman. A

Fig. 1. Luminal A type breast cancer of 37-year-old woman. A
Fig. 2. Triple negative type breast cancer of 37-year-old woman. A

Fig. 2. Triple negative type breast cancer of 37-year-old woman. A
Case Rep Gastroenterol 2015;9: DOI: /

Case Rep Gastroenterol 2015;9: DOI: /
Fig. 2. 70-year-old female with retear shows high entropy value measured by GLCM. A. Small-sized rim-rent tear of supraspinatus tendon is identified at.

Fig year-old female with retear shows high entropy value measured by GLCM. A. Small-sized rim-rent tear of supraspinatus tendon is identified at.
Fig. 1. Images of preoperative CT showing multiple neck lymph node metastases. Contrast-enhanced CT images showing multiple hyper-enhancing lymph nodes.

Fig. 1. Images of preoperative CT showing multiple neck lymph node metastases. Contrast-enhanced CT images showing multiple hyper-enhancing lymph nodes.
Fig. 7. Suspicious lymph nodes (CT features). A

Fig. 7. Suspicious lymph nodes (CT features). A
Fig. 2. A 36-year-old woman underwent right breast-conserving surgery due to invasive ductal cancer seven months prior. A mediolateral oblique mammography.

Fig. 2. A 36-year-old woman underwent right breast-conserving surgery due to invasive ductal cancer seven months prior. A mediolateral oblique mammography.
Fig. 1. Screening breast MR images of 31-year-old woman with personal history of contralateral breast cancer.Breast MRI was reported as negative finding.

Fig. 1. Screening breast MR images of 31-year-old woman with personal history of contralateral breast cancer.Breast MRI was reported as negative finding.
Fig. 2. Three lesion patterns on postmortem CT images of brain. A

Fig. 2. Three lesion patterns on postmortem CT images of brain. A
Fig. 17. A 54-year-old male with recent voice change. A

Fig. 17. A 54-year-old male with recent voice change. A
Fig. 2. Atypical response to VEGF-targeted therapy in colon cancer

Fig. 2. Atypical response to VEGF-targeted therapy in colon cancer
Fig. 5. A 13-year-old boy with epidermoid cyst of the skull

Fig. 5. A 13-year-old boy with epidermoid cyst of the skull

Similar presentations

Ads by Google